V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158272 | 20060579 | 1.81 | 71.6 | Adjuvant (A) | 2017-04-22 | 2017-04-26 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100919887 |
| 20158274 | 20060580 | 1.7 | 92.3 | Palliative (P) | 2019-02-26 | 2019-03-07 | ECX | N | N | ECX | 101245460 |
| 20158277 | 20060581 | 1.63 | 78.7 | Neo-adjuvant (N) | 2019-03-24 | 2019-03-29 | ECX | 2 | N | ECX | 100907488 |
| 20158278 | 20060582 | 1.66 | 71.7 | null | 2018-10-30 | 2018-11-08 | ECX | N | null | ECX | 100027508 |
| 20158279 | 20060583 | 1.57 | 59.6 | Neo-adjuvant (N) | 2020-06-11 | 2020-06-25 | ECX | N | N | ECX | 100385363 |
| 20158280 | 20060584 | 1.52 | null | null | 2017-12-03 | 2017-12-25 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100812604 |
| 20158282 | 20060585 | 1.61 | 51.7 | Neo-adjuvant (N) | 2019-02-17 | 2019-03-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101634226 |
| 20158283 | 20060586 | 1.57 | 65.5 | Neo-adjuvant (N) | 2019-05-17 | 2019-06-01 | ECX | N | N | ECX | 101204983 |
| 20158284 | 20060587 | null | 60 | Adjuvant (A) | 2017-05-03 | 2017-05-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100332472 |
| 20158285 | 20060588 | 1.61 | 83.55 | Neo-adjuvant (N) | 2019-12-24 | 2020-01-04 | ECX | 02 | N | ECX | 100054512 |
| 20158286 | 20060589 | 1.63 | 63.9 | Palliative (P) | 2016-03-11 | 2016-03-28 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100326266 |
| 20158289 | 20060590 | 1.59 | 73.5 | Neo-adjuvant (N) | 2019-03-30 | 2019-04-06 | ECX | N | Y | ECX | 101660643 |
| 20158290 | 20060591 | 1.79 | 58.5 | Palliative (P) | 2017-08-23 | 2017-09-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100955342 |
| 20158292 | 20060592 | 1.66 | 55 | Palliative (P) | null | 2019-04-05 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101531234 |
| 20158293 | 20060593 | 1.71 | 76.1 | Palliative (P) | 2016-09-09 | 2016-09-14 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100326022 |
| 20158295 | 20060594 | 1.71 | 83 | Palliative (P) | 2017-10-26 | 2017-10-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100477172 |
| 20158296 | 20060595 | 1.78 | 78 | Neo-adjuvant (N) | 2016-09-06 | 2016-10-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101159857 |
| 20158298 | 20060596 | 1.55 | 60.85 | Adjuvant (A) | 2019-05-25 | 2019-06-12 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100281934 |
| 20158300 | 20060597 | 1.61 | 51.7 | Adjuvant (A) | 2019-08-04 | 2019-08-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101278501 |
| 20158301 | 20060598 | 1.7 | null | Palliative (P) | 2017-02-11 | 2017-02-11 | ECX | 02 | N | ECX | 101571546 |
| 20158303 | 20060599 | 1.77 | 78 | Adjuvant (A) | 2017-12-09 | 2017-12-20 | ECX | N | N | ECX | 100017779 |
| 20158304 | 20060600 | 1.57 | 70.75 | Adjuvant (A) | 2017-08-04 | 2017-08-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100056150 |
| 20158305 | 20060601 | 1.73 | 56 | Neo-adjuvant (N) | 2018-07-12 | 2018-07-21 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 101238120 |
| 20158306 | 20060602 | 1.6 | 68.9 | Neo-adjuvant (N) | 2017-06-23 | 2017-06-30 | ECX | 2 | N | ECX | 100442726 |
| 20158307 | 20060603 | 1.73 | 78.8 | Palliative (P) | 2016-10-21 | 2016-10-24 | ECX | 02 | N | ECX | 100030244 |
| 20158311 | 20060604 | 1.71 | 101 | Palliative (P) | null | 2016-05-06 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 101011130 |
| 20158312 | 20060605 | 1.57 | 92.3 | Neo-adjuvant (N) | 2017-09-15 | 2017-09-21 | ECX | N | N | ECX | 101727528 |
| 20158314 | 20060606 | 1.66 | 76.8 | Palliative (P) | 2017-11-27 | 2017-12-06 | ECX | N | N | ECX | 101525409 |
| 20158315 | 20060607 | 1.7 | 86.5 | Neo-adjuvant (N) | 2016-11-11 | 2016-12-01 | ECX | 02 | N | ECX | 101658039 |
| 20158319 | 20060608 | 1.83 | 74.1 | Neo-adjuvant (N) | null | 2020-01-06 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100553395 |
| 20158322 | 20060609 | 1.79 | 66.4 | null | 2018-09-28 | 2018-10-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101335004 |
| 20158323 | 20060610 | 1.55 | 89.5 | Neo-adjuvant (N) | 2018-04-06 | 2018-05-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101815356 |
| 20158324 | 20060611 | null | 64.2 | Palliative (P) | 2019-10-25 | 2019-10-27 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101642142 |
| 20158327 | 20060612 | 1.73 | 83 | Adjuvant (A) | 2018-03-16 | 2018-03-17 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101818269 |
| 20158329 | 20060613 | 1.73 | 87.5 | null | 2017-10-25 | 2017-11-01 | ECX | N | N | ECX | 100915354 |
| 20158330 | 20060614 | null | null | Neo-adjuvant (N) | 2019-12-29 | 2020-01-04 | ECX | N | N | ECX | 101705310 |
| 20158332 | 20060615 | 1.67 | 90.4 | Neo-adjuvant (N) | 2016-07-20 | 2016-07-26 | ECX | N | N | ECX | 100044351 |
| 20158335 | 20060616 | 1.36 | 77.4 | Neo-adjuvant (N) | 2016-04-08 | 2016-04-19 | ECX | N | null | ECX | 101042554 |
| 20158337 | 20060617 | 1.75 | 65 | Palliative (P) | 2019-07-22 | 2019-08-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101717299 |
| 20158339 | 20060618 | 1.62 | 51.6 | Palliative (P) | 2018-02-16 | 2018-02-16 | ECX | 02 | N | ECX | 101621089 |
| 20158342 | 20060619 | 1.58 | 66 | Neo-adjuvant (N) | 2016-06-18 | 2016-07-18 | ECX | 2 | N | ECX | 100514675 |
| 20158343 | 20060620 | 1.74 | 74.4 | Neo-adjuvant (N) | 2017-04-15 | 2017-04-25 | ECX | N | N | ECX | 101297136 |
| 20158344 | 20060621 | 1.63 | 89 | null | 2019-01-03 | 2019-01-03 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100858274 |
| 20158345 | 20060622 | 1.69 | 95.8 | Palliative (P) | 2019-08-15 | 2019-08-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100709818 |
| 20158348 | 20060623 | 1.84 | 67.65 | Palliative (P) | 2018-06-14 | 2018-07-11 | ECX | N | N | ECX | 101721964 |
| 20158349 | 20060624 | 1.87 | 72 | Palliative (P) | 2016-09-19 | 2016-09-27 | Gemcitabine + Capecitabine | Y | N | CAPECITABINE + GEMCITABINE | 100925105 |
| 20158353 | 20060625 | 1.58 | 68.9 | Adjuvant (A) | 2016-08-16 | 2016-09-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101662572 |
| 20158354 | 20060626 | 1.77 | 102 | null | 2016-03-19 | 2016-03-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101615649 |
| 20158355 | 20060627 | 1.77 | 71 | Neo-adjuvant (N) | 2019-07-22 | 2019-08-01 | ECX | N | N | ECX | 101295401 |
| 20158356 | 20060628 | null | null | Curative (C) | 2017-12-21 | 2017-12-21 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101606245 |